Rivocean Jiangsu Pharmaceutical Co., Ltd. initially established in 1992, is integrated with sales, R&D and production of fine chemicals and APIs. It is located in Binhai Chemical zone of Yancheng city, Jiangsu province, China. 

Rivocean Jiangsu pays much attention to Bio-medicine industry, its products including human & veterinary drugs. According to usage, products can be divided into Antivirus, Gastrointestinal, Antibiotics, Antivirus, Cardiovascular, Central nervous system drugs. Mainly, Rivocean Jiangsu is engaged in APIs and intermediates of Efavirenz, Entecavir, Pantoprazole, Florfenicol, Phenylephrine, Agomelatine and so on. Rivocean Jiangsu has been approved by ISO, EHS and audits from global leading pharmaceutical companies. 

Its subsidiary Jingshan Ruisheng Pharm and Rivocean Hubei Pharm are located in Hubei province. Jingshan Ruisheng's main veterinary APIs are Florfenicol and Tildipirosin, both have obtained the ministry of Agriculture veterinary GMP qualification. Also Rivocean Hubei Pharm passed GMP audit for Florfenicol in the year 2023 Attached much importance to R&D, Rivocean Jiangsu owns Provincial Hi-tech R&D center. Being a good partner, Rivocean Jiangsu cooperates with global pharmaceutical companies. Rivocean Jiangsu is dedicated to expanding product portfolio and enhancing competitiveness, with aim to be a leading company which provides healthy products and service around the world. 

Rivocean Jiangsu is adhering to the enterprise concept of “cherish every drop, form river and ocean", bringing each client, supplier and employee together for long-term and mutual development.